NCT00882531View on ClinicalTrials.gov

Isotretinoin in Papular-Pustular Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Papular-pustular Rosacea
Interventions
DRUG

isotretinoin

0.25 mg/kg, 1 per day, 4 month of treatment

DRUG

placebo

Sponsors
All Listed Sponsors
collaborator

Quanta Medical

INDUSTRY

lead

Laboratoires Bailleul-Biorga

INDUSTRY

NCT00882531 - Isotretinoin in Papular-Pustular Rosacea | Biotech Hunter | Biotech Hunter